Submissions from 2024
Assessing the acceptability of, adherence to and preference for a dual prevention pill (DPP) for HIV and pregnancy prevention compared to oral pre-exposure prophylaxis (PrEP) and oral contraception taken separately: Protocols for two randomised, controlled, cross-over studies in South Africa and Zimbabwe, Barbara Friedland, Nyaradzo M. Mgodi, Thesla Palanee-Phillips, Sanyukta Mathur, Marlena Gehret Plagianos, Irene Bruce, Maud Lansiaux, Caroline Murombedzi, Petina Musara, Adlight Dandadzi, Krishnaveni Reddy, Nkosiphile Ndlovu, Sihle K. Zulu, Lerato R. Shale, Brady Zieman, and Lisa Haddad
Editorial: Multipurpose prevention technologies for HIV, STIs and pregnancies, Barbara Friedland, Andrea Ries Thurman, Harriet Nuwagaba-Biribonwoha, and R. Karl Malcolm
The Promise of Vaginal Rings: From the Global Leader in Vaginal Ring Development and Implementation, Population Council
Submissions from 2023
Does size matter? A randomized controlled trial to assess the impact of external diameter on adherence to 3 different intravaginal rings among 24 US couples, Irene Bruce, Marlena Gehret Plagianos, Jessica M. Sales, Jessica Atrio, Shakti Shetty, Caio Sant’Anna Marinho, Brady Zieman, Lisa Haddad, and Barbara Friedland
Women want choices: Opinions from the Share.Learn.Shape global internet survey about multipurpose prevention technology (MPT) products in development, Barbara Friedland, Marlena Gehret Plagianos, Craig Savel, Virginia Kallianes, C. Martinez, Lorna Begg, K.M. Guthrie, D. Venkatasetty, J. Pickett, and Lisa Haddad
Exploring user and stakeholder perspectives from South Africa and Uganda to refine microarray patch development for HIV PrEP delivery and as a multipurpose prevention technology, Ayesha Ismail, Sarah Magni, Anne Katahoire, Florence Ayebare, Godfrey Siu, Fred Semitala, Peter Kyambadde, Barbara Friedland, Courtney Jarrahian, and Maggie Kilbourne-Brook
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: A randomised, open-label, crossover trial, Gonasagrie Nair, Connie Celum, Daniel Szydlo, Elizabeth R. Brown, Carolyne Akello, Rita Nakalega, et al., and John Steytler
Center for Biomedical Research at the Population Council, Population Council
Commentary: Multipurpose prevention technologies—What about sexually transmitted infections?, Anjanique Mariquit Rosete Lu and Lisa Haddad
Coming Full Circle: Microbicide Development at the Population Council, James Sailer, Barbara Friedland, Diantha Pillay, Christopher J. Elias, Sharon L. Hillier, and Georgina Caswell
Equipping providers to offer novel MPTs: Developing counseling messages for the Dual Prevention Pill in clinical studies and beyond, Kate Segal, Danielle M. Harris, Andy Carmone, Lisa Haddad, Sanjay Hadigal, Karin Hatzold, Chris Jones, Eva Lathrop, Jennifer Mason, and Meridith Mikulich
Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a Phase 1 clinical trial: Learning from users to improve acceptability, Mary Kate Shapley-Quinn, Mei Song, Beatrice A. Chen, Brid Devlin, Ellen Luecke, Jill Brown, Diana Blithe, Sharon Achilles, and Ariane van der Straten
Submissions from 2022
Acceptability of PC-1005 gel administered rectally to HIV-1 seronegative adults at three different volume levels (MTN-037), José A. Bauermeister, Ryan C. Tingler, Ken Ho, Rachel Scheckter, Tara McClure, Jontraye Davis, Jeanna Piper, Barbara Friedland, Stacey Edick, Mei Song, Yuqing Jiao, Craig W. Hendrix, and Craig Hoesley
Results of a phase 1, randomized, placebo controlled first-in-human trial of griffithsin formulated in a carrageenan vaginal gel, Natalia Teleshova, Marla J. Keller, José Fernández-Romero, Barbara Friedland, George W. Creasy, Marlena Gehret Plagianos, Laurie Ray, Patrick Barnable, Larisa Kizima, Aixa Rodriguez, Nadjet Cornejal, Claudia Melo, Gearoff Cruz Rodriguez, Sampurna Mukhopadhyay, Giulia Calenda, Shweta U. Sinkar, Thierry Bonnaire, Asa Wesenberg, Shimin Zhang, Kyle Kleinbeck, Kenneth Palmer, Mohcine Alami, Barry R. O'Keefe, Patrick Gillevet, Hong Hur, Yupu Liang, Gabriela Santone, Raina N. Fichorova, Tamara Kalir, and Thomas Zydowsky
Transport and permeation properties of dapivirine: Understanding potential drug-drug interactions, Ruohui Zheng, Guru R. Valicherla, Junmei Zhang, Jeremy Nuttall, Peter Silvera, Leslie J. Marshall, Philip E. Empey, and Lisa C. Rohan
Submissions from 2021
Qualitative study on the acceptability of and adherence to a vaginal ring for HIV prophylaxis among adolescent girls, Zoe Baker, Marjan Javanbakht, Janell Moore, Hannah Brosnan, Kathleen Squires, Katherine Bunge, Gregory Zimet, Barbara Mensch, Lydia Soto-Torres, Bill Kapogiannis, Lisa Levy, Craig Hoesley, Daniel Reirden, Aditya Gaur, Kenneth H. Mayer, Donna Futterman, and Pamina M. Gorbach
Estimating the market size for a dual prevention pill: Adding contraception to pre-exposure prophylaxis (PrEP) to increase uptake, Lorna Begg, Rebecca Brodsky, Barbara Friedland, Sanyukta Mathur, James Sailer, and George W. Creasy
The promise of the dual prevention pill: A framework for development and introduction, Barbara Friedland, Sanyukta Mathur, and Lisa Haddad
Contraceptive technologies: Looking ahead to new approaches to increase options for family planning, Lisa Haddad, John Townsend, and Régine Sitruk-Ware
A healthy world starts with healthy women, International Partnership for Microbicides
A Long-Acting and Woman-Controlled HIV Prevention Option, International Partnership for Microbicides
A long-acting ring for women’s HIV prevention, International Partnership for Microbicides
A multipurpose prevention ring for women's sexual and reproductive health, International Partnership for Microbicides
IPM: Pioneering HIV prevention options for women, International Partnership for Microbicides
Microbicide Overview, International Partnership for Microbicides
Microbicides: Woman-centered HIV prevention to help end AIDS by 2030, International Partnership for Microbicides
Why microbicides for women?, International Partnership for Microbicides
The Promise of the Dual Prevention Pill, Sanyukta Mathur
Submissions from 2020
The benefits and limitations of donating new contraceptive technology: The case of the International Contraceptive Access (ICA) Foundation and the LNG IUS Program in Brazil, Laura Miranda, John Townsend, Anibal Faundes, and Luis Bahamondes
Commentary on research to improve contraceptive and multipurpose prevention technologies, J. Joseph Speidel, John Townsend, Elspeth Williams, Jamie Quam, and Kirsten M.J. Thompson
Submissions from 2019
Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques, Giulia Calenda, Ines Frank, Geraldine Arrode-Bruses, Amarendra Pegu, Keyun Wang, James Arthos, Claudia Cicala, Kenneth A. Rogers, Lisa Shirreff, Brooke Grasperge, James L. Blanchard, Stephanie Maldonado, Kevin Roberts, Agegnehu Gettie, Francois Villinger, Anthony S. Fauci, John R. Mascola, and Elena Martinelli
Topical formulations to prevent sexually transmitted infections: Are we on track?, José Fernández-Romero, Maria Gabriela Paglini, and Thomas Zydowsky
After the Ring Study: DREAM, International Partnership for Microbicides
Understanding women’s motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence, Ariana Katz, Barbara Mensch, Kubashini Woeber, Petina Musara, Juliane Etima, and Ariane van der Straten
Vaginal ring use in a phase 3 microbicide trial: A comparison of objective measures and self-reports of non-adherence in ASPIRE, Barbara Mensch, Barbara Richardson, Marla Husnik, Elizabeth R. Brown, Flavia Matovu Kiweewa, Ashley Mayo, Jared M. Baeten, Thesla Palanee-Phillips, Ariane van der Straten, and MTN-020-ASPIRE Study Team
Submissions from 2018
Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo, Nina Derby, Manjari Lal, Meropi Aravantinou, Larisa Kizima, Patrick Barnable, Aixa Rodriguez, Manshun Lai, Asa Wesenberg, Shweta Ugaonkar, Keith Levendosky, Olga Mizenina, Kyle Kleinbeck, Jeffrey D. Lifson, M. Melissa Peet, Zachary Lloyd, Michael Benson, Walid Heneine, Barry R. O'Keefe, Melissa Robbiani, Elena Martinelli, Brooke Grasperge, James Blanchard, Agegnehu Gettie, Natalia Teleshova, José Fernández-Romero, and Thomas Zydowsky
Development of a vaginal fast-dissolving insert combining griffithsin and carrageenan for potential use against sexually transmitted infections, Manjari Lal, Manshun Lai, Shweta Ugaonkar, Asa Wesenberg, Larisa Kizima, Aixa Rodriguez, Keith Levendosky, Olga Mizenina, José Fernández-Romero, and Thomas Zydowsky
How presentation of drug detection results changed reports of product adherence in South Africa, Uganda and Zimbabwe, Petina Musara, Elizabeth T. Montgomery, Nyaradzo M. Mgodi, Kubashini Woeber, Carolyne Akello, Miriam Hartmann, Helen Cheng, Lisa Levy, Ariana Katz, Cynthia I. Grossman, Zvavahera M. Chirenje, Ariane van der Straten, Barbara Mensch, and Microbicide Trials Network-003D Study Team
Do women find the progesterone vaginal ring acceptable? Findings from Kenya, Nigeria, and Senegal, Saumya RamaRao, Francis Obare, Salisu Mohammed Ishaku, Babacar Mane, Heather Clark, Wilson Liambila, Godwin Unumeri, Harriet Birungi, Nafissatou Diop, Deepa Rajamani, and John Townsend
Effects of concurrent vaginal miconazole treatment on the absorption and exposure of Nestorone® (segesterone acetate) and ethinyl estradiol delivered from a contraceptive vaginal ring: A randomized, crossover drug–drug interaction study, Katharine B. Simmons, Narender Kumar, Marlena Gehret Plagianos, Kevin Roberts, Elena Hoskin, Leo Han, Mohcine Alami, George W. Creasy, Bruce Variano, and Ruth Merkatz
Submissions from 2017
MZC gel inhibits SHIV-RT and HSV-2 in macaque vaginal mucosa and SHIV-RT in rectal mucosa, Giulia Calenda, Guillermo Villegas, Patrick Barnable, Claudia Litterst, Keith Levendosky, Agegnehu Gettie, Michael Cooney, James Blanchard, José Fernández-Romero, Thomas Zydowsky, and Natalia Teleshova
An intravaginal ring that releases three antiviral agents and a contraceptive blocks SHIV-RT infection, reduces HSV-2 shedding, and suppresses hormonal cycling in rhesus macaques, Nina Derby, Meropi Aravantinou, Jessica Kenney, Shweta Ugaonkar, Asa Wesenberg, Jolanta Wilk, Larisa Kizima, Aixa Rodriguez, Shimin Zhang, Olga Mizenina, Keith Levendosky, Michael Cooney, Samantha Seidor, Agegnehu Gettie, Brooke Grasperge, James Blanchard, Michael Piatak Jr., Jeffrey D. Lifson, José Fernández-Romero, Thomas Zydowsky, and Melissa Robbiani
Achieving the optimal vaginal state: Using vaginal products and study gels in Uganda, Zimbabwe, and South Africa, Zoe Duby, Barbara Mensch, Miriam Hartmann, Elizabeth T. Montgomery, Imelda Mahaka, Linda-Gail Bekker, and Ariane van der Straten
2017 IPM Annual Report—Women & HIV Prevention: Expanding the Options, Empowering Women, International Partnership for Microbicides
MIV-150 and zinc acetate combination provides potent and broad activity against HIV-1, Olga Mizenina, Mayla Hsu, Ninochka Jean-Pierre, Meropi Aravantinou, Keith Levendosky, Maria Gabriela Paglini, Thomas Zydowsky, Melissa Robbiani, and José Fernández-Romero
Misreporting of product adherence in the MTN-003/VOICE trial for HIV prevention in Africa: Participants’ explanations for dishonesty, Elizabeth T. Montgomery, Barbara Mensch, Petina Musara, Miriam Hartmann, Kubashini Woeber, Juliane Etima, and Ariane van der Straten
Submissions from 2016
Condoms, lubricants and rectal cleansing: Practices associated with heterosexual penile-anal intercourse amongst participants in an HIV prevention trial in South Africa, Uganda and Zimbabwe, Zoe Duby, Miriam Hartmann, Elizabeth T. Montgomery, Christopher J. Colvin, Barbara Mensch, and Ariane van der Straten
A first-in-human trial of MIV-150 and zinc acetate co-formulated in a carrageenan gel: Safety, pharmacokinetics, acceptability, adherence and pharmacodynamics, Barbara Friedland, Craig Hoesley, Marlena Gehret Plagianos, Elena Hoskin, Shimin Zhang, Natalia Teleshova, Mohcine Alami, Lea Novak, Kyle Kleinbeck, Lauren L. Katzen, Thomas Zydowsky, José Fernández-Romero, and George W. Creasy
Baseline predictors of high adherence to a coitally dependent microbicide gel based on an objective marker of use: Findings from the Carraguard Phase 3 Trial, Barbara Friedland, Marie Stoner, Michelle Chau, Marlena Gehret Plagianos, Sumentheran N. Govender, Neetha S. Morar, Lydia Altini, Stephanie Skoler-Karpoff, Khatija Ahmed, Gita Ramjee, Constance Monedi, Robin A. Maguire, and Pekka Lahteenmaki
2016 IPM Annual Report—Hope, Progress and the Power of Prevention, International Partnership for Microbicides
HIV Prevention for Women: The Promise of the Ring, International Partnership for Microbicides
Microbicides: Developing New HIV Prevention Options for Women, International Partnership for Microbicides
New technologies for women's HIV prevention: The payoff for sustainable development, International Partnership for Microbicides
Multipurpose prevention approaches with antiretroviral-based formulations, Ninochka Jean-Pierre, Patrick Barnable, Larisa Kizima, Aixa Rodriguez, Samantha Seidor, Michael Cooney, Meredith R. Clark, Gustavo F. Doncel, Melissa Robbiani, Thomas Zydowsky, Natalia Teleshova, and José Fernández-Romero
In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel, Akiva P. Novetsky, Marla J. Keller, Ana Gradissimo, Zigui Chen, Stephanie L. Morgan, Xiaonan Xue, Howard D. Strickler, José Fernández-Romero, Robert Burk, and Mark H. Einstein
Introducing the progesterone contraceptive vaginal ring in sub-Saharan Africa, Population Council
Progesterone vaginal ring: Beneficial role in supporting breastfeeding, Population Council
A novel microbicide/contraceptive intravaginal ring protects macaque genital mucosa against SHIV-RT infection ex vivo, Guillermo Villegas, Giulia Calenda, Shweta Ugaonkar, Shimin Zhang, Larisa Kizima, Olga Mizenina, Agegnehu Gettie, James Blanchard, Michael Cooney, Melissa Robbiani, José Fernández-Romero, Thomas Zydowsky, and Natalia Teleshova
In vitro exposure to PC-1005 and cervicovaginal lavage fluid from women vaginally administered PC-1005 inhibits HIV-1 and HSV-2 infection in human cervical mucosa, Guillermo Villegas, Giulia Calenda, Shimin Zhang, Olga Mizenina, Kyle Kleinbeck, Michael Cooney, Craig Hoesley, George W. Creasy, Barbara Friedland, José Fernández-Romero, Thomas Zydowsky, and Natalia Teleshova
Submissions from 2015
Learning from women about HIV risk, HIV testing behaviors, and prevention practices in Mpumalanga, South Africa: A descriptive study to inform microbicides introduction, Martha Brady, Saiqa Mullick, Barbara Friedland, Marlena Gehret Plagianos, Linda Du Plessis, and Thabiso Mango
Multipurpose prevention technologies: The future of HIV and STI protection, José Fernández-Romero, Carolyn Deal, Betsy C. Herold, John Schiller, Dorothy Patton, Thomas Zydowsky, Joseph W. Romano, Christopher D. Petro, and Manjulaa Narasimhan
Preclinical assessments of vaginal microbicide candidate safety and efficacy, José Fernández-Romero, Natalia Teleshova, Thomas Zydowsky, and Melissa Robbiani
2015 IPM Annual Report—New Hope for Women's HIV Prevention, International Partnership for Microbicides
To tell or not to tell: Male partner engagement in a Phase 3 microbicide efficacy trial in South Africa, Christine A. Kelly, Barbara Friedland, Neetha S. Morar, Lauren L. Katzen, Gita Ramjee, Mathila Mokgatle, and Khatija Ahmed
Griffithsin and carrageenan combination to target herpes simplex virus 2 and human papillomavirus, Keith Levendosky, Olga Mizenina, Elena Martinelli, Ninochka Jean-Pierre, Larisa Kizima, Aixa Rodriguez, Kyle Kleinbeck, Thierry Bonnaire, Melissa Robbiani, Thomas Zydowsky, Barry R. O'Keefe, and José Fernández-Romero
ARV-based HIV prevention for women: State of the science and considerations for implementation in Zimbabwe. Report from a provider workshop, Population Council
Introducing antiretroviral (ARV)-based prevention products for women: A guide to strategic decisionmaking and planning, Population Council
Safety, pharmacokinetics and acceptability of PC-1005 for vaginal use, Population Council
Using a 2-stage strategy with respondent-driven sampling to recruit a hard-to-reach population for a placebo microbicide gel clinical trial in Nellore, Andhra Pradesh (India), Waimar Tun, Lauren L. Katzen, Sharon Abbott, Aylur K. Srikrishnan, Christine A. Kelly, Avina Sarna, Barbara Friedland, Suniti Solomon, and Barbara Mensch
An intravaginal ring for the simultaneous delivery of an HIV-1 maturation inhibitor and reverse-transcriptase inhibitor for prophylaxis of HIV transmission, Shweta Ugaonkar, Justin T. Clark, Lexie B. English, Todd J. Johnson, Karen W. Buckheit, Robert J. Bahde, Daniel H. Appella, Robert W. Buckheit Jr., and Patrick F. Kiser
A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy, Shweta Ugaonkar, Asa Wesenberg, Jolanta Wilk, Samantha Seidor, Olga Mizenina, Larisa Kizima, Aixa Rodriguez, Shimin Zhang, Keith Levendosky, Jessica Kenney, Meropi Aravantinou, Nina Derby, Brooke Grasperge, Agegnehu Gettie, James F. Blanchard, Narender Kumar, Kevin Roberts, Melissa Robbiani, José Fernández-Romero, and Thomas Zydowsky
Disclosure of pharmacokinetic drug results to understand nonadherence, Ariane van der Straten, Elizabeth T. Montgomery, Petina Musara, Juliane Etima, Sarita Naidoo, Nicole Laborde, Miriam Hartmann, Lisa Levy, Thola Bennie, Helen Cheng, Jeanna Piper, Cynthia I. Grossman, Jeanne Marrazzo, and Barbara Mensch
Submissions from 2014
A MIV-150/zinc acetate gel inhibits SHIV-RT infection in macaque vaginal explants, Patrick Barnable, Giulia Calenda, Louise Ouattara, Agegnehu Gettie, James Blanchard, Ninochka Jean-Pierre, Larisa Kizima, Aixa Rodriguez, Ciby J. Abraham, Radhika Menon, Samantha Seidor, Michael Cooney, Kevin Roberts, Rhoda Sperling, Michael Piatak Jr., Jeffrey D. Lifson, José Fernández-Romero, Thomas Zydowsky, Melissa Robbiani, and Natalia Teleshova
Aligning product development and user perspectives: Social-behavioural dimensions of multipurpose prevention technologies, Martha Brady and Elizabeth E. Tolley
First-in-human safety and pharmacokinetics (PK) of a MIV-150/zinc acetate/carrageenan gel (PC-1005), George W. Creasy, Craig Hoesley, Barbara Friedland, Shimin Zhang, Marlena Gehret Plagianos, Kyle Kleinbeck, Keith Levendosky, José Fernández-Romero, and Thomas Zydowsky
Policy and programme considerations for ARV-based prevention for women: Insights from key opinion leaders in Zimbabwe about tenofovir gel, Samukeliso Dube, Barbara Friedland, Saiqa Mullick, Martha Brady, and C. Elizabeth McGrory
Microbicidas para la prevención de infecciones de transmisión sexual: estado actual y estrategias para la evaluación preclínica de nuevos candidatos, José Fernández-Romero, Pedro I. Gil, Viviana Re, Melissa Robbiani, and Gabriela Paglini
Vaginal expression of efflux transporters and the potential impact on the disposition of microbicides in vitro and in rabbits, Carolien Grammen, Myriam Baes, Steven Haenen, Jasper Verguts, Koen Augustyns, Thomas Zydowsky, Paolo La Colla, Patrick Augustijns, and Joachim Brouwers
A combination microbicide gel protects macaques against vaginal SHIV-RT infection, but only partially reduces HSV-2 infection after a single high-dose co-challenge, Mayla Hsu, Meropi Aravantinou, Radhika Menon, Samantha Seidor, Daniel Goldman, Jessica Kenney, Nina Derby, Agegnehu Gettie, James Blanchard, Michael Piatak Jr., Jeffrey D. Lifson, José Fernández-Romero, Thomas Zydowsky, and Melissa Robbiani
Exposure to MIV-150 from a high-dose intravaginal ring results in limited emergence of drug resistance mutations in SHIV-RT infected rhesus macaques, Mayla Hsu, Brandon F. Keele, Meropi Aravantinou, Noa Krawczyk, Samantha Seidor, Ciby J. Abraham, Shimin Zhang, Aixa Rodriguez, Larisa Kizima, Nina Derby, Ninochka Jean-Pierre, Olga Mizenina, Agegnehu Gettie, Brooke Grasperge, James Blanchard, Michael Piatak Jr., Jeffrey D. Lifson, José Fernández-Romero, Thomas Zydowsky, and Melissa Robbiani
2014 IPM Annual Report—The Promise of Prevention for Women, International Partnership for Microbicides
MZC and 1% TFV gel: Multipurpose prevention approaches, Ninochka Jean-Pierre, Patrick Barnable, Larisa Kizima, Aixa Rodriguez, Samantha Seidor, Meredith R. Clark, Gustavo F. Doncel, Melissa Robbiani, Thomas Zydowsky, Natalia Teleshova, and José Fernández-Romero
Short communication: A repeated simian human immunodeficiency virus reverse transcriptase/herpes simplex virus type 2 cochallenge macaque model for the evaluation of microbicides, Jessica Kenney, Nina Derby, Meropi Aravantinou, Kyle Kleinbeck, Ines Frank, Agegnehu Gettie, Brooke Grasperge, James Blanchard, Michael Piatak Jr., Jeffrey D. Lifson, Thomas Zydowsky, and Melissa Robbiani
A potent combination microbicide that targets SHIV-RT, HSV-2 and HPV, Larisa Kizima, Aixa Rodriguez, Jessica Kenney, Nina Derby, Olga Mizenina, Radhika Menon, Samantha Seidor, Shimin Zhang, Keith Levendosky, Ninochka Jean-Pierre, Pavel Pugach, Guillermo Villegas, Brian E. Ford, Agegnehu Gettie, James F. Blanchard, Michael Piatak Jr., Jeffrey D. Lifson, Maria Gabriela Paglini, Natalia Teleshova, Thomas Zydowsky, Melissa Robbiani, and José Fernández-Romero
Engaging male partners in women's microbicide use: Evidence from clinical trials and implications for future research and microbicide introduction, Michele Lanham, Rose Wilcher, Elizabeth T. Montgomery, Robert Pool, Sidney Schuler, Rachel Lenzi, and Barbara Friedland
Antiviral activity and mode of action of Griffithsin against HSV-2 and HPV: Preliminary studies of a potential non-ARV combination microbicide, Keith Levendosky, Olga Mizenina, Kyle Kleinbeck, Larisa Kizima, Aixa Rodriguez, Ninochka Jean-Pierre, Melissa Robbiani, Barry R. O'Keefe, Thomas Zydowsky, and José Fernández-Romero
MIV-150-containing intravaginal rings protect macaque vaginal explants against SHIV-RT infection, Louise Ouattara, Patrick Barnable, Paul Mawson, Samantha Seidor, Thomas Zydowsky, Larisa Kizima, Aixa Rodriguez, José Fernández-Romero, Michael Cooney, Kevin Roberts, Agegnehu Gettie, James Blanchard, Melissa Robbiani, and Natalia Teleshova
An overview of the HIV prevention landscape in Zimbabwe: Implications for tenofovir gel, Population Council
Program and policy considerations for tenofovir gel in India: An overview, Population Council
Setting the stage for ARV-based prevention for women: A snapshot of the Zimbabwean context, Population Council
Tenofovir gel for HIV prevention for women: Perspectives of key opinion leaders from India, Abhijit Prabhughate, Avina Sarna, and Martha Brady
In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition, Aixa Rodriguez, Kyle Kleinbeck, Olga Mizenina, Larisa Kizima, Keith Levendosky, Ninochka Jean-Pierre, Guillermo Villegas, Brian E. Ford, Michael Cooney, Natalia Teleshova, Melissa Robbiani, Betsy C. Herold, Thomas Zydowsky, and José Fernández-Romero
Enrollment of adolescents aged 16–17 years old in microbicide trials: An evidence-based approach, Katie D. Schenk, Barbara Friedland, Michelle Chau, Marie Stoner, Marlena Gehret Plagianos, Stephanie Skoler-Karpoff, Thesla Palanee-Phillips, Khatija Ahmed, Mary-Jane Malebo Ratlhagana, Pamela Nombali Mthembu, and Nomampondomise Ngcozela
Socioeconomic and behavioral factors influencing choice, adherence and success of microbicide formulations, Elizabeth E. Tolley, Barbara Friedland, Mitzy Gafos, K. Rivet Amico, Lut Van Damme, Cynthia Woodsong, Kathleen M. MacQueen, Leila Mansoor, and Sheena McCormack
A novel intravaginal ring (IVR) protects macaques against SHIV-RT infection and reduces HSV-2 shedding after repeated SHIV-RT/HSV-2 co-challenge, Thomas Zydowsky, Jessica Kenney, Meropi Aravantinou, Shweta Ugaonkar, Nina Derby, Larisa Kizima, Shimin Zhang, Olga Mizenina, José Fernández-Romero, and Melissa Robbiani
Submissions from 2013
An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India, Sharon Abbott, Barbara Friedland, Avina Sarna, Lauren L. Katzen, Ulrike Rawiel, Aylur K. Srikrishnan, C.S. Shalini, Waimar Tun, Christine A. Kelly, Suniti Solomon, and Barbara Mensch
Lessons from reproductive health to inform multipurpose prevention technologies: Don't reinvent the wheel, Martha Brady and Judy Manning
In search of the optimal delivery method for anti-HIV microbicides: Are intravaginal rings the way forward?, Nina Derby, Thomas Zydowsky, and Melissa Robbiani
Effect of computer-assisted interviewing on self-reported sexual behavior data in a microbicide clinical trial, Pamina M. Gorbach, Barbara Mensch, Marla Husnik, Astou Coly, Benoit R. Masse, Bonus Makanani, Chiwawa Nkhoma, Lameck Chinula, Tchangani Tembo, Stanley J. Mierzwa, Kimberly Reynolds, Stacey Hurst, Anne S. Coletti, and Andrew Forsyth
2013 IPM Annual Report—Responding to Women’s Needs: Developing HIV and Multipurpose Prevention Products, International Partnership for Microbicides